BioSpace News Archive

Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, senior vice president, chief financial officer, and chief transformation officer will participate in a fireside chat at the UBS MedTech, Tools and Genomics Summit 2023 on Tues., Aug. 15 at approximately 1:00 p.m. Pacific Time.

SK bioscience, an innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that its board of directors has decided to make an equity investment in Novavax, a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, securing 6.5 million shares of common stock through a private placement.

GeneDx, a leader in delivering improved health outcomes through genomic and clinical insights, announced that, effective as of August 8, 2023, the compensation committee of GeneDx’s board of directors granted newly-hired employees 23,769 restricted stock units as inducements material to each employee entering into employment with GeneDx.

Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”) today announced that it will report financial results for the first half of 2023 ended June 30, 2023 and provide a business update on August 24, 2023.

Belite Bio, Inc (NASDAQ: BLTE) (“Belite” or the “Company”) today announced its financial results for the three months ended June 30, 2023 and provided a general business update.

Benitec Biopharma Inc. announced the pricing of its underwritten public offering of 15,544,041 shares of its common stock and accompanying warrants to purchase up to 15,544,041 shares of common stock.